ASP Isotopes Inc. (NASDAQ:ASPI) Shares Sold by Alyeska Investment Group L.P.

Alyeska Investment Group L.P. cut its holdings in ASP Isotopes Inc. (NASDAQ:ASPI - Free Report) by 53.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 347,022 shares of the company's stock after selling 400,000 shares during the quarter. Alyeska Investment Group L.P. owned 0.49% of ASP Isotopes worth $1,572,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Hanson & Doremus Investment Management purchased a new stake in shares of ASP Isotopes during the 4th quarter worth approximately $27,000. B. Riley Wealth Advisors Inc. purchased a new stake in ASP Isotopes in the 3rd quarter valued at approximately $42,000. Avantax Advisory Services Inc. acquired a new stake in ASP Isotopes during the 4th quarter valued at $45,000. Russell Investments Group Ltd. raised its holdings in shares of ASP Isotopes by 56.3% in the fourth quarter. Russell Investments Group Ltd. now owns 10,221 shares of the company's stock worth $46,000 after acquiring an additional 3,682 shares during the last quarter. Finally, SVB Wealth LLC purchased a new stake in shares of ASP Isotopes in the fourth quarter valued at $49,000. Institutional investors and hedge funds own 16.80% of the company's stock.

Insider Transactions at ASP Isotopes

In related news, COO Robert Ainscow sold 66,668 shares of the firm's stock in a transaction that occurred on Thursday, April 17th. The shares were sold at an average price of $5.62, for a total value of $374,674.16. Following the sale, the chief operating officer now directly owns 1,419,992 shares of the company's stock, valued at approximately $7,980,355.04. This trade represents a 4.48% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Paul Elliot Mann sold 316,667 shares of the company's stock in a transaction that occurred on Tuesday, April 15th. The stock was sold at an average price of $5.75, for a total transaction of $1,820,835.25. Following the transaction, the chief executive officer now directly owns 7,948,787 shares of the company's stock, valued at $45,705,525.25. This trade represents a 3.83% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 766,667 shares of company stock worth $4,358,502 over the last ninety days. 21.40% of the stock is currently owned by corporate insiders.

ASP Isotopes Price Performance

ASPI stock traded up $0.04 during trading on Monday, hitting $6.47. The stock had a trading volume of 994,492 shares, compared to its average volume of 1,919,006. ASP Isotopes Inc. has a 1-year low of $1.86 and a 1-year high of $9.33. The stock has a market cap of $485.65 million, a price-to-earnings ratio of -10.61 and a beta of 3.40. The company's 50 day moving average price is $4.96 and its two-hundred day moving average price is $5.40. The company has a debt-to-equity ratio of 0.80, a quick ratio of 7.54 and a current ratio of 7.55.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.